Changes of serum cytokines-related Th1/Th2/Th17 concentration in patients with postmenopausal osteoporosis

Gynecological Endocrinology

Volumn 31, Issue 3, 2015, Pages 183-190

  Zhang, Jing ^a   Fu, Qin ^a   Ren, Zhaozhou ^a   Wang, Yanjun ^a   Wang, Chenchen ^a   Shen, Tao ^a   Wang, Guangbin ^a   Wu, Lina ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine; Osteoporosis; Postmenopausal

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MAGNESIUM; PHOSPHORUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LIMIT OF DETECTION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE RELATED DISORDER; OSTEOPENIA; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSAL OSTEOPENIA; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TH2 CELL; BLOOD; MIDDLE AGED;

ALKALINE PHOSPHATASE; CALCIUM; CYTOKINES; FEMALE; HUMANS; MAGNESIUM; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHOSPHORUS;

EID: 84931397236     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.975683     Document Type: Article

References (43)

1. Tyagi AM, Srivastava K, Mansoori MN, et al. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One 2012; 7: e44552
2. DeSelm CJ, Takahata Y, Warren J, et al. IL-17 mediates estrogendeficient osteoporosis in an Act1-dependent manner. J Cell Biochem 2012; 113: 2895-902
3. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995; 332: 305-11
4. Ralston SH. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 1994; 9: 883-90
5. Lacey DL, Erdmann JM, Teitelbaum SL, et al. Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 1995; 136: 2367-76
6. Bendixen AC, Shevde NK, Dienger KM, et al. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc Natl Acad Sci U S A 2001; 98: 2443-8
7. Kamel MS, Sugiyama E, Shinoda K, et al. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis. Biochem Biophys Res Commun 2005; 329: 839-45
8. Miossec P, Chomarat P, Dechanet J, et al. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum 1994; 37: 1715-22
9. Riancho JA, Zarrabeitia MT, Gonzalez-Macias J. Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures. Biochem Biophys Res Commun 1993; 196: 678-85
10. Takayanagi H, Sato K, Takaoka A, Taniguchi T. Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 2005; 208: 181-93
11. Xu Z, Hurchla MA, Deng H, et al. Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases. J Biol Chem 2009; 284: 4658-66
12. Gao Y, Grassi F, Ryan MR, et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 2007; 117: 122-32
13. Weitzmann MN, Pacifici R. The role of T lymphocytes in bone metabolism. Immunol Rev 2005; 208: 154-68
14. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 2006; 116: 1186-94
15. Morita Y, Yamamura M, Kawashima M, et al. Flow cytometric single-cell analysis of cytokine production by CD4+T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 1669-76
16. Steiner G, Tohidast-Akrad M, Witzmann G, et al. Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 202-13
17. Partsch G, Wagner E, Leeb BF, et al. T cell derived cytokines in psoriatic arthritis synovial fluids. Ann Rheum Dis 1998; 57: 691-3
18. Nelson ER, Wardell SE, Jasper JS, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science 2013; 342: 1094-8
19. Neumark DE, Sheon N, Palefsky J. Investigating motivations for participation in an anal cancer screening trial (IMPACT). Sex Health 2013; 10: 583-4
20. Marsh K, Snow RW. 30 years of science and technology: the example of malaria. Lancet 1997; 349(Suppl 3): S1-S2. pii: http://dx.doi.org/10.1016/S0140-6736(97)90063-5
21. Van Vlasselaer P, Borremans B, Van Gorp U, et al. Interleukin 10 inhibits transforming growth factor-beta (TGF-beta) synthesis required for osteogenic commitment of mouse bone marrow cells. J Cell Biol 1994; 124: 569-77
22. Owens JM, Gallagher AC, Chambers TJ. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J Immunol 1996; 157: 936-40
23. Molnar I, Bohaty I, Somogyine-Vari E. High prevalence of increased interleukin-17A serum levels in postmenopausal estrogen deficiency. Menopause 2014; 21: 749-52
24. Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 2008; 41: 92-104
25. Qian Y, Liu C, Hartupee J, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007; 8: 247-56
26. Chang SH, Park H, Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 2006; 281: 35603-7
27. Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006; 203: 2673-82
28. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8: 942-9
29. Pene J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008; 180: 7423-30
30. Li X, Yuan FL, Lu WG, et al. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis. Biochem Biophys Res Commun 2010; 397: 131-5
31. Yago T, Nanke Y, Ichikawa N, et al. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17. J Cell Biochem 2009; 108: 947-55
32. Ji JD, Park-Min KH, Shen Z, et al. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol 2009; 183: 7223-33
33. Duque G, Huang DC, Macoritto M, et al. Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells 2009; 27: 550-8
34. Rifas L. T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization. J Cell Biochem 2006; 98: 706-14
35. Sir Cooper A. A treatise on dislocations and on fractures of the joints: fractures of the neck of the thigh-bone. 1823. Clin Orthop Relat Res 2007; 458: 6-7.
36. Ershler WB, Harman SM, Keller ET. Immunologic aspects of osteoporosis. Dev Comp Immunol 1997; 21: 487-99.
37. Evans KE, Fox SW. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol 2007; 8: 4.
38. Gur A, Denli A, Nas K, et al. Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy. Rheumatol Int 2002; 22: 194-8.
39. Gumus P, Buduneli E, Biyikoglu B, et al. Gingival crevicular fluid and serum levels of APRIL, BAFF and TNF-alpha in rheumatoid arthritis and osteoporosis patients with periodontal disease. Arch Oral Biol 2013; 58: 1302-8.
40. Furuta I, Kobayashi N, Fujino T, et al. Bone mineral density of the lumbar spine is associated with TNF gene polymorphisms in early postmenopausal Japanese women. Calcif Tissue Int 2004; 74: 509-15.
41. Whiteside TL. Cytokine assays. Biotechniques 2002; Suppl: 4-8, 10, 12-15.
42. Czerny B, Kaminski A, Kurzawski M, et al. The association of IL-1beta, IL-2, and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2010; 149: 82-5.
43. Park BL, Han IK, Lee HS, et al. Association of interleukin 10 haplotype with low bone mineral density in Korean postmenopausal women. J Biochem Mol Biol 2004; 37: 691-9.